International Private Wealth Advisors LLC Increases Position in UnitedHealth Group Incorporated (NYSE:UNH)

International Private Wealth Advisors LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 722 shares of the healthcare conglomerate’s stock after purchasing an additional 88 shares during the quarter. International Private Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $365,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Panoramic Capital Partners LLC bought a new position in UnitedHealth Group in the 4th quarter worth approximately $684,000. Arlington Trust Co LLC raised its stake in shares of UnitedHealth Group by 27.6% during the 4th quarter. Arlington Trust Co LLC now owns 2,323 shares of the healthcare conglomerate’s stock valued at $1,175,000 after purchasing an additional 502 shares during the period. Equitable Trust Co. grew its holdings in UnitedHealth Group by 6.4% during the 4th quarter. Equitable Trust Co. now owns 11,590 shares of the healthcare conglomerate’s stock valued at $5,863,000 after buying an additional 699 shares in the last quarter. Soltis Investment Advisors LLC boosted its position in shares of UnitedHealth Group by 17.2% in the fourth quarter. Soltis Investment Advisors LLC now owns 21,444 shares of the healthcare conglomerate’s stock valued at $10,848,000 after acquiring an additional 3,148 shares during the period. Finally, Elser Financial Planning Inc purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $524,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Price Performance

UNH opened at $533.17 on Tuesday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The business’s fifty day simple moving average is $529.18 and its 200-day simple moving average is $564.40. The company has a market capitalization of $490.66 billion, a price-to-earnings ratio of 34.40, a PEG ratio of 1.45 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue was up 6.8% compared to the same quarter last year. During the same period last year, the business posted $5.83 EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. TD Cowen lifted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Bank of America lowered their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Oppenheimer raised their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.